Mulroy Michael H. Insider Trades

Insider Trading History

Track insider trading activity for Mulroy Michael H.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Director
Holding Value $90.8k 75,000 shares
Last Trade
Jul 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$67.5k 75,000 shares
$0.90
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Director
Holding Value $361k 298,555 shares
Last Trade
Nov 22, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$20.2k 40,000 shares
$0.50
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Director
Holding Value $90.8k 75,000 shares
Last Trade
Jul 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$71.3k 75,000 shares
$0.95
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Director
Holding Value $60.5k 50,000 shares
Last Trade
Jul 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$70.5k 50,000 shares
$1.41
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Director
Holding Value $60.5k 50,000 shares
Last Trade
Jul 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$157k 100,000 shares
$1.57
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Director
Holding Value $313k 258,555 shares
Last Trade
Mar 24, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$9.8k 7,000 shares
$1.40
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Director
Holding Value $60.5k 50,000 shares
Last Trade
Jul 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$143k 50,000 shares
$2.86
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Director
Holding Value $0 0 shares
Last Trade
Jun 18, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$66.7k 24,720 shares
$2.70
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Director
Holding Value $304k 251,555 shares
Last Trade
Jun 18, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$66.7k 24,720 shares
$2.70
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Director
Holding Value $48.4k 40,000 shares
Last Trade
Jul 01, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$33.2k 40,000 shares
$0.83
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Director
Holding Value $48.4k 40,000 shares
Last Trade
Jul 01, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$41.2k 40,000 shares
$1.03
$1.21
Eterna Therapeutics
Eterna Therapeutics ERNA
Director
Holding Value $328k 40,000 shares
Last Trade
Jul 01, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$89M 40,000 shares
$2,226.00
$8.19
AgeX Therapeutics
AgeX Therapeutics AGE
Director
Holding Value $722k 65,000 shares
Last Trade
Mar 11, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$278k 65,000 shares
$4.28
$11.10
Eterna Therapeutics
Eterna Therapeutics ERNA
Director
Holding Value $1.86M 226,821 shares
Last Trade
Mar 08, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$404M 194,271 shares
$2,082.00
$8.19
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Director
Holding Value $274k 226,821 shares
Last Trade
Mar 08, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$254k 194,271 shares
$1.31
$1.21
AgeX Therapeutics
AgeX Therapeutics AGE
Director
Holding Value $0 0 shares
Last Trade
Nov 27, 2018 Sale
No data
No data
$11.10
Eterna Therapeutics
Eterna Therapeutics ERNA
Director
Holding Value $328k 40,000 shares
Last Trade
Jul 01, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$107M 40,000 shares
$2,664.00
$8.19
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Director
Holding Value $48.4k 40,000 shares
Last Trade
Jul 01, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$82.4k 40,000 shares
$2.06
$1.21
Eterna Therapeutics
Eterna Therapeutics ERNA
Director
Holding Value $164k 20,000 shares
Last Trade
Jul 01, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$81.6M 20,000 shares
$4,080.00
$8.19
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Director
Holding Value $24.2k 20,000 shares
Last Trade
Jul 01, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$63k 20,000 shares
$3.15
$1.21

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up